Mutagenic impurities

This abstract image represents ion mobility as used in IMS-MS, a key technology for nitrosamine detection in pharmaceutical quality control. By visualizing particle separation, it underscores IMS-MS's role in ensuring regulatory compliance and improving impurity profiling.
Articles
| 3 min read
Understand the essentials of QbD for HPLC and create robust, reproducible methods for pharmaceutical applications.
Blogs
Available On-Demand
Learn more about the risk assessment and analytical challenges of detection and quantification of trace level impurities in pharmaceuticals.
Blogs
| 1 min read
Analysis of nitrosamines in pharmaceuticals presents certain unique challenges - interferences, elevated baselines, inconsistencies in quantifications, decreased method performance.
Blogs
| 2 min read
Why are there nitrosamines in drug substances and drug products, and what are the current regulatory guidance’s to help identify these mutagenic impurities?
close-up view of an abstract molecular structure concept of biology and science (3d render)
Blogs

GC/MS strategies for mutagenic impurities analysis

| 2 min read